IXYS Corporation (NASDAQ:IXYS), an international power semiconductor and IC company, today announced financial results for its third fiscal quarter ended December 31, 2016.
Net revenues for the quarter ended December 31, 2016 were $79.5 million, an increase of 5.8%, as compared to $75.1 million in net revenues from the December 2015 quarter. Sequentially, net revenues in the December 2016 quarter increased by $855,000 from net revenues of $78.6 million posted in the September 2016 quarter. For the nine months ended December 31, 2016, IXYS reported net revenues of $238.8 million, as compared to net revenues of $237.4 million for the same period in the prior fiscal year.
“Higher revenues, in combination with aggressive cost-cutting initiatives and the focus on optimizing our worldwide enterprise, have allowed IXYS to improve its results. We continued our investments in new products and technologies in order to support our growth,” commented Dr. Nathan Zommer, Founder and CEO of IXYS.
Net income for the quarter ended December 31, 2016 was $5.1 million, or $0.16 per diluted share, an increase of $2.8 million, or 123.1%, as compared to net income of $2.3 million, or $0.07 per diluted share, for the December 2015 quarter. Sequentially, net income in the December 2016 quarter increased by $1.2 million, or 29.6%, from net income of $3.9 million in the September 2016 quarter.
The December 2016 quarter non-GAAP net income, which excludes the impact of charges for the amortization and impairment of acquired intangible assets and for stock compensation, was $7.8 million, or $0.24 per diluted share, as compared to non-GAAP net income of $3.9 million, or $0.12 per diluted share, for the same period in the prior fiscal year.
Net income for the nine-month period ended December 31, 2016 was $12.1 million, or $0.38 per diluted share, an increase of $3.5 million, or 41.1%, as compared to net income of $8.5 million, or $0.26 per diluted share, for the same period in the prior fiscal year. For the nine months ended December 31, 2016, non-GAAP net income was $17.5 million, or $0.55 per diluted share, as compared to non-GAAP net income of $14.3 million, or $0.44 per diluted share, for the same period in the prior fiscal year.
Gross profit for the quarter ended December 31, 2016 was $26.9 million, or 33.9% of net revenues, as compared to gross profit of $24.0 million, or 32.0% of net revenues, for the same quarter in the prior fiscal year. On a sequential basis, the December 2016 quarter gross profit margin increased by 150 basis points from 32.4% of net revenues, or $25.5 million of gross profit, in the September 2016 quarter. Gross profit for the nine months ended December 31, 2016 was $76.4 million, or 32.0% of net revenues, as compared to gross profit of $75.6 million, or 31.9% of net revenues, for the same period in the prior fiscal year.
Cash and cash equivalents totaled $158.5 million at December 31, 2016, after generating $11.5 million in cash from operations during the quarter. Adjusted EBITDA, which excludes stock-based compensation expense and charges for the impairment of acquired intangible assets, was $12.9 million for the December 2016 quarter and $33.3 million for the nine-month period ended December 31, 2016.
“Political uncertainty materially held back growth in 2016 as customers were reticent to make forecasts, preferring to purchase as needed on short lead times. IXYS was able to adapt to these conditions, securing new customers and stabilizing revenue trends. With various governmental elections decided by the end of 2016, focus has returned to economic development worldwide. Bookings are up and our backlog remains strong,” stated Mr. Uzi Sasson, CEO and President of IXYS. “Therefore, we are cautiously optimistic about our prospects and expect revenues in the March 2017 quarter to increase 3% from the December 2016 quarter.”
Non-GAAP Information
Included above and within the attached schedules are certain non-GAAP financial figures. The company incurred non-cash charges, including those associated with the amortization and impairment of intangible assets and stock compensation. Adjusting the net income to exclude the impact of the amortization and impairment of acquired intangible assets and stock compensation expenses and the tax on the stock compensation expense at the effective tax rate for the respective periods results in a financial presentation for the company without the effect of these non-cash charges. Similarly, adjusted EBITDA reflects the exclusion of depreciation and amortization, charges for impairment of acquired intangible assets, stock compensation expenses, interest and taxes, and may serve as an indication of the company’s ability to service its debt. Management believes non-GAAP net income, non-GAAP net income per share and adjusted EBITDA are useful measures of operating performance. However, the non-GAAP measures should be considered in addition to, not as a substitute for or superior to, net income and net income per share or other financial measures prepared in accordance with GAAP.
These non-GAAP measures have limitations as analytical tools, and should not be considered in isolation or as substitutes for analysis of our results as reported under GAAP. Other companies in our industry may calculate non-GAAP net income, non-GAAP net income per share and adjusted EBITDA differently than we do, limiting their usefulness as comparative measures.
About IXYS Corporation
Since its founding in Silicon Valley, IXYS Corporation has been developing technology-driven products to improve energy conversion efficiency, generate clean energy, improve automation, and provide advanced products for the transportation, medical and telecommunication industries. IXYS, with its subsidiaries, is a worldwide pioneer in the development of power semiconductors, solid state relays, high voltage integrated circuits, and microcontrollers that are necessary in conserving energy and in reducing the world’s dependence on fossil fuels.
Diminishing natural resources, demand for renewable energy and environmental directives for energy efficiency represent a significant challenge. IXYS’ power semiconductors and mixed-signal integrated circuits play a vital role in reducing energy costs and consumption by optimizing the energy efficiency of everyday products. IXYS semiconductors are also key to developments of new medical devices and systems that provide unique solutions in diagnostics and therapy for the leading medical equipment OEMs worldwide. With an end-customer base of over 3,500 telecommunications, transportation, industrial, medical and consumer companies, IXYS is a worldwide recognized provider of advanced semiconductors.
Additional information may be obtained by visiting IXYS’ website at http://www.ixys.com, or by contacting the company directly.
Safe Harbor Statement
The foregoing press release contains forward-looking statements, including those related to supporting growth, the focus on economic development, bookings, backlog and our revenues in the March 2017 quarter. Actual results may vary materially from those contained in the forward-looking statements, due to changes in customer delivery schedules, the cancellation of orders, an unanticipated decline in our business, increased competition, cash flow difficulties, unanticipated technological hurdles, manufacturing challenges, capacity limitations, adverse changes in customer demand, declining economic conditions, increasing product costs or changes in currency exchange rates, among other things. Further information on other factors that could affect IXYS is detailed and included in reports that IXYS has filed with the Securities and Exchange Commission, including its Form 10-Q for the fiscal quarter ended September 30, 2016. IXYS undertakes no obligation to publicly release the results of any revisions to these forward-looking statements.
IXYS CORPORATION | ||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
| (in thousands) | ||||||||
| (unaudited) | ||||||||
| December 31, | March 31, | |||||||
| 2016 | 2016 | |||||||
ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 158,493 | $ | 155,806 | ||||
| Restricted cash | 1,309 | 277 | ||||||
| Accounts receivable, net | 36,715 | 38,440 | ||||||
| Inventories, net | 87,118 | 89,604 | ||||||
| Prepaid expenses and other current assets | 5,996 | 4,203 | ||||||
| Total current assets | 289,631 | 288,330 | ||||||
| Property, plant and equipment, net | 41,738 | 42,623 | ||||||
| Other assets | 62,938 | 63,724 | ||||||
| Deferred income taxes | 27,774 | 28,024 | ||||||
| Total assets | $ | 422,081 | $ | 422,701 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Current portion of notes payable to bank | 976 | 1,804 | ||||||
| Accounts payable | 11,214 | 11,416 | ||||||
| Accrued expenses and other current liabilities | 25,208 | 21,290 | ||||||
| Total current liabilities | 37,398 | 34,510 | ||||||
| Notes payable and other liabilities, net of current portion | 84,140 | 92,589 | ||||||
| Pension liabilities | 14,348 | 16,307 | ||||||
| Total liabilities | 135,886 | 143,406 | ||||||
| Common stock | 383 | 382 | ||||||
| Additional paid-in capital | 156,729 | 152,200 | ||||||
| Retained earnings | 157,717 | 146,979 | ||||||
| Accumulated other comprehensive (loss) | (28,634 | ) | (20,266 | ) | ||||
| Stockholders' equity | 286,195 | 279,295 | ||||||
| Total liabilities and stockholders' equity | $ | 422,081 | $ | 422,701 | ||||
| IXYS CORPORATION | ||||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
| (in thousands, except per share data) | ||||||||||||||||
| (unaudited) | ||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2016 | 2015 | 2016 | 2015 | |||||||||||||
| Net revenues | $ | 79,484 | $ | 75,133 | $ | 238,751 | $ | 237,437 | ||||||||
| Cost of goods sold | 52,545 | 51,104 | 162,363 | 161,794 | ||||||||||||
| Gross profit | 26,939 | 24,029 | 76,388 | 75,643 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Research, development and engineering | 6,703 | 7,280 | 22,461 | 22,767 | ||||||||||||
| Selling, general and administrative | 10,276 | 9,158 | 30,454 | 29,595 | ||||||||||||
| Amortization of acquired intangible assets | 750 | 1,329 | 2,463 | 4,282 | ||||||||||||
| Impairment of acquired intangible assets | 1,391 | -- | 1,391 | -- | ||||||||||||
| Total operating expenses | 19,120 | 17,767 | 56,769 | 56,644 | ||||||||||||
| Operating income | 7,819 | 6,262 | 19,619 | 18,999 | ||||||||||||
| Other (expense) income, net | (675 | ) | (88 | ) | (409 | ) | (2,400 | ) | ||||||||
| Income before income tax provision | 7,144 | 6,174 | 19,210 | 16,599 | ||||||||||||
| Provision for income tax | 2,044 | 3,888 | 7,156 | 8,055 | ||||||||||||
| Net income | $ | 5,100 | $ | 2,286 | $ | 12,054 | $ | 8,544 | ||||||||
| Net income per share - basic | $ | 0.16 | $ | 0.07 | $ | 0.38 | $ | 0.27 | ||||||||
| Weighted average shares used in per share calculation - basic | 31,558 | 31,487 | 31,484 | 31,626 | ||||||||||||
| Net income per share - diluted | $ | 0.16 | $ | 0.07 | $ | 0.38 | $ | 0.26 | ||||||||
| Weighted average shares used in per share calculation - diluted | 32,209 | 32,343 | 32,119 | 32,483 | ||||||||||||
Reconciliation of net income to non-GAAP net income (in thousands, unaudited): | ||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2016 | 2015 | 2016 | 2015 | |||||||||||||
| Net income | $ | 5,100 | $ | 2,286 | $ | 12,054 | $ | 8,544 | ||||||||
| Amortization and impairment of acquired intangible assets | 2,141 | 1,329 | 3,854 | 4,282 | ||||||||||||
| Stock compensation expense | 822 | 838 | 2,551 | 2,777 | ||||||||||||
| Tax on stock compensation expense | (235 | ) | (528 | ) | (950 | ) | (1,348 | ) | ||||||||
| Non-GAAP net income | $ | 7,828 | $ | 3,925 | $ | 17,509 | $ | 14,255 | ||||||||
Reconciliation of net income per share, diluted to non-GAAP net income per share, diluted (unaudited): | ||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2016 | 2015 | 2016 | 2015 | |||||||||||||
| Net income per share, diluted | $ | 0.16 | $ | 0.07 | $ | 0.38 | $ | 0.26 | ||||||||
| Amortization and impairment of acquired intangible assets | 0.06 | 0.04 | 0.12 | 0.13 | ||||||||||||
| Stock compensation expense | 0.03 | 0.03 | 0.08 | 0.09 | ||||||||||||
| Tax on stock compensation expense | (0.01 | ) | (0.02 | ) | (0.03 | ) | (0.04 | ) | ||||||||
| Non-GAAP net income per share, diluted | $ | 0.24 | $ | 0.12 | $ | 0.55 | $ | 0.44 | ||||||||
| Weighted average shares used in per share calculation, diluted | 32,209 | 32,343 | 32,119 | 32,483 | ||||||||||||
| Adjusted EBITDA (in thousands, unaudited) | |||||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| December 31, | December 31, | ||||||||||||||||
| 2016 | 2015 | 2016 | 2015 | ||||||||||||||
| Net income | $ | 5,100 | $ | 2,286 | $ | 12,054 | $ | 8,544 | |||||||||
| Add: | |||||||||||||||||
| Income tax expense | 2,044 | 3,888 | 7,156 | 8,055 | |||||||||||||
| Interest expense | 646 | 432 | 1,896 | 1,030 | |||||||||||||
| Impairment of acquired-intangible assets | 1,391 | -- | 1,391 | -- | |||||||||||||
| Depreciation and amortization | 2,906 | 3,333 | 8,273 | 10,478 | |||||||||||||
| Stock compensation expense | 822 | 838 | 2,551 | 2,777 | |||||||||||||
| Adjusted EBITDA | $ | 12,909 | $ | 10,777 | $ | 33,321 | $ | 30,884 | |||||||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20170202006107/en/
Contacts:
President & CEO
IXYS Corporation
1590
Buckeye Drive
Milpitas, California 95035
(408) 457-9000
